Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of TER-2013 …
Breast CancerEndometrial CancerOvarian Cancer+5 more
Estimated
~$10 – $8,750
Terremoto Biosciences Inc.NCT07109726
Phase 1
A Modular Phase I/IIa, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is saf…
Ovarian CancerLung AdenocarcinomaEndometrial Cancer+1 more
Estimated
~$10 – $7,500
AstraZenecaNCT05797168